1 April 2010 in Pacing and Clinical Electrophysiology
1 May 2013 in Circulation: Heart Failure
Background—: Cardiac resynchronization therapy improves mortality and morbidity in patients with heart failure (HF) with wide QRS complex and diminished left ventricular (LV) function, but response is variable. Methods and Results—: The Speckle Tracking Assisted Resynchronization Therapy for Electrode Region (STARTER) was a prospective, double-blind, randomized controlled trial testing the hypothesis that an incremental benefit to cardiac resynchronization therapy would be gained by echo-guided (EG) transvenous LV lead placement versus a routine fluoroscopic approach. EG LV lead placement was attempted at the site of latest time to peak radial strain by speckle tracking echocardiography. The prespecified primary end point was first HF hospitalization or death. Of 187 New York Heart Association class II to IV patients with HF (62% ischemic; ejection fraction 26±6%; QRS 159±27 ms), 110 were randomized to EG and 77 to routine strategies. Primary events included 30 deaths and 37 HF hospitalizations over 1.8 years. Using intention-to-treat, patients randomized to an EG strategy had a significantly more favorable event-free survival (hazard ratio, 0.48; 95% confidence interval, 0.28–0.82; P =0.006). Exact or adjacent concordance of LV lead with latest site could be achieved in 85% of the EG group and occurred fortuitously in 66% of controls ( P =0.010) and was associated with an improvement in event-free survival (hazard ratio, 0.40; 95% confidence interval, 0.22–0.71; P =0.002). Conclusions—: A strategy of EG LV lead placement for cardiac resynchronization therapy improved patient outcomes by reducing the combined risk of death or HF hospitalizations and has implications for delivery of cardiac resynchronization therapy. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00156390.
18 May 2009 in Clinical Cardiology
Background: Cardiac arrhythmias and conduction abnormalities complicating acute myocardial infarction (AMI) have been associated with adverse prognosis in numerous reports. Small studies have frequently associated different arrhythmias with various distributions of myocardial infarctions. We analyzed a nationally representative hospital discharge database to evaluate the relationship between the location of AMI and the associated arrhythmias and conduction abnormalities and their impact on in‐hospital mortality.Methods: We searched the National Hospital Discharge Survey database for patients with a diagnosis of AMI and collected data on the associated arrhythmias and conduction abnormalities. In‐hospital death was used as end point for analysis.Results: A total of 21,807 patients, representing 2,632,217 hospital discharges in the United States, with a primary diagnosis of AMI from 1996 to 2003 were included in this analysis. Patients with inferior or posterior AMI were more likely to develop complete heart block compared to those with anterior or lateral AMI (3.7% vs 1.0%, hazard ratio [HR] = 3.9, p ≤ 0.001), but less likely to die prior to hospital discharge (7.7% vs 11.3%, HR = 0.65, p ≤ 0.001).Conclusions: Patients with an inferior or posterior AMI are more likely to develop conduction system abnormalities when compared to patients with an anterior or lateral AMI. On the other hand, anterior or lateral MI is a significant predictor of in‐hospital death. Copyright
30 March 2021 in Circulation
1 April 2006 in American Heart Journal
1 January 2017 in Journal of Cardiology